Concepts (257)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caveolin 1 | 13 | 2024 | 257 | 4.620 |
Why?
|
| Receptors, Mineralocorticoid | 15 | 2024 | 164 | 3.430 |
Why?
|
| Aldosterone | 26 | 2023 | 868 | 2.450 |
Why?
|
| Sodium Chloride, Dietary | 14 | 2024 | 293 | 1.680 |
Why?
|
| Sodium, Dietary | 11 | 2023 | 425 | 1.670 |
Why?
|
| Hypertension | 28 | 2024 | 8594 | 1.510 |
Why?
|
| Blood Pressure | 28 | 2024 | 8525 | 1.260 |
Why?
|
| Angiotensin II | 10 | 2023 | 849 | 1.150 |
Why?
|
| Vasoconstriction | 6 | 2015 | 593 | 1.120 |
Why?
|
| Histone Demethylases | 7 | 2022 | 323 | 1.070 |
Why?
|
| Calmodulin-Binding Proteins | 6 | 2020 | 232 | 0.950 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2013 | 1485 | 0.940 |
Why?
|
| Zona Glomerulosa | 6 | 2022 | 87 | 0.880 |
Why?
|
| Spironolactone | 7 | 2020 | 411 | 0.770 |
Why?
|
| Nitric Oxide Synthase Type III | 5 | 2013 | 704 | 0.750 |
Why?
|
| Renin-Angiotensin System | 9 | 2019 | 738 | 0.690 |
Why?
|
| Renin | 7 | 2017 | 635 | 0.690 |
Why?
|
| Lysine | 2 | 2022 | 1001 | 0.640 |
Why?
|
| Caloric Restriction | 2 | 2018 | 296 | 0.630 |
Why?
|
| Insulin Resistance | 7 | 2018 | 3959 | 0.620 |
Why?
|
| Dinucleoside Phosphates | 3 | 2004 | 73 | 0.610 |
Why?
|
| Aorta | 8 | 2015 | 2039 | 0.600 |
Why?
|
| Oxidoreductases, N-Demethylating | 3 | 2012 | 110 | 0.570 |
Why?
|
| Nitric Oxide | 4 | 2015 | 2141 | 0.540 |
Why?
|
| Signal Transduction | 18 | 2024 | 23376 | 0.530 |
Why?
|
| Cyclic GMP | 3 | 2015 | 395 | 0.490 |
Why?
|
| Vasodilation | 3 | 2015 | 962 | 0.490 |
Why?
|
| Endothelium, Vascular | 7 | 2013 | 4433 | 0.460 |
Why?
|
| Mice, Knockout | 15 | 2022 | 14372 | 0.450 |
Why?
|
| NG-Nitroarginine Methyl Ester | 6 | 2023 | 260 | 0.430 |
Why?
|
| Nerve Tissue Proteins | 6 | 2020 | 4407 | 0.420 |
Why?
|
| Muscle Relaxation | 2 | 2010 | 138 | 0.420 |
Why?
|
| Receptor, Angiotensin, Type 1 | 3 | 2024 | 148 | 0.400 |
Why?
|
| Kidney Diseases | 1 | 2023 | 2093 | 0.400 |
Why?
|
| Fumarates | 1 | 2012 | 131 | 0.390 |
Why?
|
| Cardiovascular System | 2 | 2015 | 850 | 0.360 |
Why?
|
| Adenosine Triphosphate | 4 | 2004 | 1993 | 0.350 |
Why?
|
| Amides | 1 | 2012 | 448 | 0.340 |
Why?
|
| Animals | 45 | 2024 | 167963 | 0.340 |
Why?
|
| Blood Glucose | 4 | 2018 | 6381 | 0.320 |
Why?
|
| Mice | 24 | 2023 | 81208 | 0.320 |
Why?
|
| Membrane Proteins | 6 | 2020 | 7850 | 0.320 |
Why?
|
| Kidney | 9 | 2023 | 7064 | 0.300 |
Why?
|
| Cardiovascular Diseases | 5 | 2024 | 15757 | 0.300 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 1902 | 0.300 |
Why?
|
| Epoprostenol | 3 | 2004 | 248 | 0.280 |
Why?
|
| Nitric Oxide Synthase | 1 | 2010 | 908 | 0.280 |
Why?
|
| Cardiomegaly | 1 | 2010 | 593 | 0.280 |
Why?
|
| Adrenal Glands | 3 | 2020 | 554 | 0.280 |
Why?
|
| Rats, Wistar | 9 | 2023 | 1850 | 0.270 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2006 | 213 | 0.250 |
Why?
|
| Luciferases | 2 | 2004 | 716 | 0.250 |
Why?
|
| Vasoconstrictor Agents | 5 | 2015 | 651 | 0.240 |
Why?
|
| Hyperglycemia | 1 | 2013 | 1380 | 0.240 |
Why?
|
| Diet, Sodium-Restricted | 3 | 2017 | 291 | 0.240 |
Why?
|
| Glucose | 1 | 2016 | 4351 | 0.240 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2024 | 15789 | 0.240 |
Why?
|
| Adenine Nucleotides | 1 | 2004 | 111 | 0.230 |
Why?
|
| Homeostasis | 4 | 2020 | 3306 | 0.220 |
Why?
|
| Antihypertensive Agents | 2 | 2013 | 2061 | 0.220 |
Why?
|
| Resistin | 2 | 2016 | 172 | 0.220 |
Why?
|
| Albuminuria | 3 | 2023 | 659 | 0.200 |
Why?
|
| Vasodilator Agents | 4 | 2011 | 978 | 0.200 |
Why?
|
| Guanylate Cyclase | 2 | 2013 | 205 | 0.200 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2023 | 3334 | 0.190 |
Why?
|
| Male | 43 | 2024 | 359744 | 0.190 |
Why?
|
| Dyslipidemias | 2 | 2020 | 895 | 0.180 |
Why?
|
| Citrulline | 1 | 2000 | 106 | 0.170 |
Why?
|
| Cytosol | 1 | 2003 | 887 | 0.170 |
Why?
|
| Insulin | 5 | 2017 | 6597 | 0.170 |
Why?
|
| Aminopeptidases | 1 | 2019 | 95 | 0.170 |
Why?
|
| Myocardium | 4 | 2020 | 4700 | 0.160 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2019 | 293 | 0.160 |
Why?
|
| Genetic Variation | 2 | 2011 | 6551 | 0.150 |
Why?
|
| Metabolic Diseases | 1 | 2024 | 686 | 0.150 |
Why?
|
| Sex Factors | 6 | 2024 | 10547 | 0.150 |
Why?
|
| Zona Reticularis | 1 | 2017 | 8 | 0.140 |
Why?
|
| Cattle | 5 | 2004 | 3847 | 0.140 |
Why?
|
| Genotype | 7 | 2024 | 12960 | 0.140 |
Why?
|
| RNA, Messenger | 5 | 2023 | 12766 | 0.140 |
Why?
|
| Nucleotides | 3 | 2024 | 450 | 0.140 |
Why?
|
| Estrogen Receptor beta | 1 | 2017 | 168 | 0.140 |
Why?
|
| Triglycerides | 2 | 2016 | 2476 | 0.140 |
Why?
|
| Aldehyde Reductase | 1 | 2016 | 71 | 0.140 |
Why?
|
| Gene Frequency | 4 | 2016 | 3615 | 0.130 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 94 | 0.130 |
Why?
|
| Arginine | 1 | 2000 | 934 | 0.130 |
Why?
|
| Potassium | 1 | 2020 | 1313 | 0.130 |
Why?
|
| Epigenesis, Genetic | 3 | 2022 | 3758 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 4573 | 0.130 |
Why?
|
| Calcium | 3 | 2003 | 5725 | 0.120 |
Why?
|
| Blotting, Western | 3 | 2014 | 5039 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2024 | 2058 | 0.120 |
Why?
|
| Captopril | 2 | 2013 | 265 | 0.120 |
Why?
|
| Cholesterol | 3 | 2020 | 2924 | 0.110 |
Why?
|
| Enzyme Inhibitors | 3 | 2015 | 3726 | 0.110 |
Why?
|
| Phenylephrine | 2 | 2015 | 293 | 0.110 |
Why?
|
| Caveolins | 1 | 2014 | 102 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 5 | 2023 | 22023 | 0.110 |
Why?
|
| Heart Injuries | 1 | 2015 | 208 | 0.110 |
Why?
|
| Hypertriglyceridemia | 1 | 2016 | 316 | 0.110 |
Why?
|
| Cells, Cultured | 6 | 2021 | 18957 | 0.100 |
Why?
|
| Heart | 2 | 2019 | 4393 | 0.100 |
Why?
|
| Estrogens | 2 | 2022 | 1520 | 0.100 |
Why?
|
| Rats | 8 | 2023 | 23711 | 0.100 |
Why?
|
| Alleles | 3 | 2020 | 6898 | 0.100 |
Why?
|
| Luminescent Measurements | 2 | 2004 | 378 | 0.100 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 667 | 0.100 |
Why?
|
| Endothelial Cells | 3 | 2011 | 3539 | 0.100 |
Why?
|
| Nucleic Acid Conformation | 1 | 2015 | 899 | 0.100 |
Why?
|
| Phenotype | 6 | 2014 | 16546 | 0.100 |
Why?
|
| Hydroxycholecalciferols | 1 | 2011 | 44 | 0.090 |
Why?
|
| Sex Characteristics | 1 | 2021 | 2629 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2013 | 10827 | 0.090 |
Why?
|
| Receptors, Purinergic P2 | 2 | 2004 | 151 | 0.090 |
Why?
|
| Obesity | 1 | 2013 | 12922 | 0.090 |
Why?
|
| Binding, Competitive | 2 | 2004 | 1142 | 0.090 |
Why?
|
| Angiotensinogen | 1 | 2011 | 161 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 600 | 0.090 |
Why?
|
| Calcifediol | 1 | 2011 | 161 | 0.090 |
Why?
|
| Female | 23 | 2024 | 391270 | 0.090 |
Why?
|
| Adiponectin | 2 | 2017 | 1115 | 0.090 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 1175 | 0.080 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 18137 | 0.080 |
Why?
|
| Models, Biological | 2 | 2011 | 9467 | 0.080 |
Why?
|
| Substrate Specificity | 2 | 2004 | 1792 | 0.070 |
Why?
|
| Random Allocation | 1 | 2012 | 2394 | 0.070 |
Why?
|
| Acetylcholine | 1 | 2010 | 629 | 0.070 |
Why?
|
| Haplotypes | 2 | 2011 | 2764 | 0.070 |
Why?
|
| Humans | 30 | 2024 | 760621 | 0.070 |
Why?
|
| Isometric Contraction | 1 | 2008 | 146 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2010 | 484 | 0.070 |
Why?
|
| Receptors, Cell Surface | 2 | 2011 | 2825 | 0.070 |
Why?
|
| Models, Animal | 2 | 2011 | 2117 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2019 | 8313 | 0.070 |
Why?
|
| Parathyroid Hormone | 1 | 2013 | 1797 | 0.070 |
Why?
|
| Adipose Tissue | 2 | 2016 | 3301 | 0.070 |
Why?
|
| Aorta, Thoracic | 2 | 2011 | 1097 | 0.070 |
Why?
|
| Xanthenes | 2 | 2003 | 72 | 0.070 |
Why?
|
| Middle Aged | 15 | 2024 | 220352 | 0.060 |
Why?
|
| Metformin | 1 | 2013 | 912 | 0.060 |
Why?
|
| Sodium | 2 | 2023 | 1594 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 1974 | 0.060 |
Why?
|
| Models, Molecular | 1 | 2015 | 5434 | 0.060 |
Why?
|
| Adult | 14 | 2024 | 219994 | 0.060 |
Why?
|
| Genetic Markers | 1 | 2011 | 2608 | 0.060 |
Why?
|
| Fasting | 1 | 2011 | 1603 | 0.060 |
Why?
|
| Hemodynamics | 2 | 2014 | 4174 | 0.060 |
Why?
|
| Chromatography, Thin Layer | 1 | 2004 | 212 | 0.060 |
Why?
|
| Tritium | 1 | 2004 | 707 | 0.060 |
Why?
|
| Calcium Channel Blockers | 2 | 1997 | 694 | 0.050 |
Why?
|
| Autoradiography | 1 | 2004 | 730 | 0.050 |
Why?
|
| Body Weight | 2 | 2008 | 4611 | 0.050 |
Why?
|
| Bradykinin | 1 | 2003 | 208 | 0.050 |
Why?
|
| Polymorphism, Genetic | 2 | 2006 | 4291 | 0.050 |
Why?
|
| Arteriosclerosis | 2 | 1997 | 1064 | 0.050 |
Why?
|
| Secretory Pathway | 1 | 2021 | 53 | 0.050 |
Why?
|
| Systole | 2 | 2006 | 947 | 0.050 |
Why?
|
| Pravastatin | 1 | 2023 | 393 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 3150 | 0.050 |
Why?
|
| Sodium Chloride | 1 | 2023 | 591 | 0.050 |
Why?
|
| Liver | 1 | 2016 | 7509 | 0.050 |
Why?
|
| Alkaline Phosphatase | 1 | 2004 | 865 | 0.050 |
Why?
|
| Fluorescence | 1 | 2003 | 751 | 0.040 |
Why?
|
| Stroke | 1 | 2023 | 9962 | 0.040 |
Why?
|
| Simvastatin | 1 | 2023 | 352 | 0.040 |
Why?
|
| Aniline Compounds | 2 | 2003 | 1069 | 0.040 |
Why?
|
| Suramin | 1 | 2000 | 34 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2006 | 1112 | 0.040 |
Why?
|
| Risk Factors | 5 | 2019 | 74359 | 0.040 |
Why?
|
| Genetic Association Studies | 3 | 2017 | 2717 | 0.040 |
Why?
|
| Diltiazem | 2 | 1997 | 131 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2006 | 988 | 0.040 |
Why?
|
| Pulse | 1 | 1998 | 218 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2024 | 41335 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 13451 | 0.040 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2017 | 56 | 0.040 |
Why?
|
| Fluorescent Dyes | 2 | 2003 | 1913 | 0.040 |
Why?
|
| Sulfones | 1 | 2020 | 447 | 0.040 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2017 | 83 | 0.040 |
Why?
|
| Age Factors | 3 | 2019 | 18416 | 0.040 |
Why?
|
| Mutation | 2 | 2020 | 29932 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 17624 | 0.040 |
Why?
|
| Sirolimus | 1 | 2024 | 1547 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 11903 | 0.030 |
Why?
|
| Adolescent | 3 | 2017 | 87810 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2017 | 17790 | 0.030 |
Why?
|
| Corticosterone | 1 | 2017 | 304 | 0.030 |
Why?
|
| Nifedipine | 1 | 1996 | 221 | 0.030 |
Why?
|
| Diastole | 1 | 1998 | 788 | 0.030 |
Why?
|
| Aged | 6 | 2017 | 169152 | 0.030 |
Why?
|
| Biological Transport | 1 | 2000 | 2086 | 0.030 |
Why?
|
| Young Adult | 3 | 2017 | 58741 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2017 | 296 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 2014 | 2558 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 1998 | 1377 | 0.030 |
Why?
|
| Pyrroles | 1 | 2020 | 1137 | 0.030 |
Why?
|
| NAD | 1 | 2017 | 609 | 0.030 |
Why?
|
| Aging | 1 | 2012 | 8651 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2011 | 12914 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 1998 | 3465 | 0.020 |
Why?
|
| Caveolin 3 | 1 | 2011 | 24 | 0.020 |
Why?
|
| Body Height | 1 | 1998 | 1570 | 0.020 |
Why?
|
| Parathyroid Glands | 1 | 2013 | 517 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2006 | 3455 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 877 | 0.020 |
Why?
|
| Binding Sites | 1 | 2000 | 6048 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2024 | 4938 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1997 | 1523 | 0.020 |
Why?
|
| Diuretics | 1 | 2013 | 613 | 0.020 |
Why?
|
| Hyperaldosteronism | 1 | 2013 | 244 | 0.020 |
Why?
|
| Aortic Valve | 2 | 1997 | 1996 | 0.020 |
Why?
|
| Hormones | 1 | 2014 | 867 | 0.020 |
Why?
|
| Diet | 1 | 2008 | 8010 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2017 | 1607 | 0.020 |
Why?
|
| Time Factors | 3 | 2020 | 40165 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 1996 | 1155 | 0.020 |
Why?
|
| Gene Expression | 1 | 2021 | 7588 | 0.020 |
Why?
|
| Coronary Vessels | 2 | 1997 | 3112 | 0.020 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2011 | 540 | 0.020 |
Why?
|
| Epigenomics | 1 | 2014 | 936 | 0.020 |
Why?
|
| Genetics, Medical | 1 | 2010 | 336 | 0.020 |
Why?
|
| Diabetes Mellitus | 2 | 2016 | 5889 | 0.020 |
Why?
|
| Mesocricetus | 2 | 1997 | 252 | 0.020 |
Why?
|
| Heart Rate | 1 | 1998 | 4179 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2448 | 0.020 |
Why?
|
| Streptozocin | 1 | 2006 | 194 | 0.020 |
Why?
|
| Edema | 1 | 2010 | 769 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 2138 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 1996 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 6068 | 0.020 |
Why?
|
| Genetic Testing | 1 | 1998 | 3531 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2006 | 555 | 0.010 |
Why?
|
| Osteopontin | 1 | 2006 | 302 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2023 | 54303 | 0.010 |
Why?
|
| Cricetinae | 2 | 1997 | 2427 | 0.010 |
Why?
|
| Cytokines | 1 | 2017 | 7343 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 12293 | 0.010 |
Why?
|
| Protein Binding | 1 | 2014 | 9335 | 0.010 |
Why?
|
| Skin Diseases | 1 | 2010 | 1089 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2011 | 3682 | 0.010 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 2001 | 80 | 0.010 |
Why?
|
| Linear Models | 1 | 2011 | 5877 | 0.010 |
Why?
|
| Indomethacin | 1 | 2001 | 326 | 0.010 |
Why?
|
| Vitamin D | 1 | 2013 | 3291 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2011 | 25942 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2001 | 687 | 0.010 |
Why?
|
| Maleates | 1 | 1997 | 18 | 0.010 |
Why?
|
| Diet, Atherogenic | 1 | 1997 | 93 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 12159 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2017 | 24123 | 0.010 |
Why?
|
| Enalapril | 1 | 1997 | 313 | 0.010 |
Why?
|
| Cardiovascular Agents | 1 | 2001 | 867 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1997 | 1754 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 12626 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2001 | 2282 | 0.010 |
Why?
|
| Aspirin | 1 | 2001 | 3364 | 0.000 |
Why?
|
Concepts
(257)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(27)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_